Study Data from American Cancer Society Update Knowledge of Cancer (Health Insurance Status and Cancer Stage At Diagnosis and Survival In the United States): Cancer

2022 AUG 04 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Cancer is the subject of a report. According to news reporting originating in Atlanta, Georgia, by NewsRx journalists, research stated, “Previous studies using data from the early 2000s demonstrated that patients who were uninsured were more likely to present with late-stage disease and had worse short-term survival after cancer diagnosis in the United States. In this report, the authors provide comprehensive data on the associations of health insurance coverage type with stage at diagnosis and long-term survival in individuals aged 18-64 years who were diagnosed between 2010 and 2013 with 19 common cancers from the National Cancer Database, with survival follow-up through December 31, 2019.”

The news reporters obtained a quote from the research from American Cancer Society, “Compared with privately insured patients, Medicaid-insured and uninsured patients were significantly more likely to be diagnosed with late-stage (III/IV) cancer for all stageable cancers combined and separately. For all stageable cancers combined and for six cancer sites-prostate, colorectal, non-Hodgkin lymphoma, oral cavity, liver, and esophagus-uninsured patients with Stage I disease had worse survival than privately insured patients with Stage II disease. Patients without private insurance coverage had worse short-term and long-term survival at each stage for all cancers combined; patients who were uninsured had worse stage-specific survival for 12 of 17 stageable cancers and had worse survival for leukemia and brain tumors.”

According to the news reporters, the research concluded: “Expanding access to comprehensive health insurance coverage is crucial for improving access to cancer care and outcomes, including stage at diagnosis and survival.”

This research has been peer-reviewed.

For more information on this research see: Health Insurance Status and Cancer Stage At Diagnosis and Survival In the United States. CA: A Cancer Journal for Clinicians, 2022. CA: A Cancer Journal for Clinicians can be contacted at: Wiley, 111 River St, Hoboken 07030-5774, NJ, USA.

Our news correspondents report that additional information may be obtained by contacting Jingxuan Zhao, American Cancer Society, Surveillance & Hlth Equ Sci, Atlanta, GA 30329, United States. Additional authors for this research include Xuesong Han, Leticia Nogueira, Ahmedin Jemal, K. Robin Yabroff, Stacey A. Fedewa and Michael T. Halpern.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.3322/caac.21732. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)